ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
37 hedge funds and large institutions have $751K invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
3% more funds holding
Funds holding: 36 → 37 (+1)
16% less call options, than puts
Call options by funds: $37K | Put options by funds: $44K
57% less capital invested
Capital invested by funds: $1.73M → $751K (-$977K)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$34K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$14.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13K |
| 5 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
+$8.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$147K |
| 2 |
TCM
Tenor Capital Management
New York
|
-$78.9K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$61K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$48K |
| 5 |
Goldman Sachs
New York
|
-$16K |
RCPI Hedge Fund Activity: Q3 2015 in Review
37 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q3 2015, worth a combined $751K — down 57% from $1.73M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RCPI positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $35.3K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $147K sold.
- 37 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q3 2015, up from 36 in Q2 2015.
- Funds reported $751K of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q3 2015, down 57% quarter-over-quarter.
- 7 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q3 2015 and 5 closed out, a net change of +2 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2015 was Geode Capital Management, an estimated $35.3K added.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q3 2015 was Susquehanna International Group, an estimated $147K sold.
Based on aggregated 13F filings for Q3 2015.